Correspondence | Published:

Response to 'A cancer immunosurveillance controversy'

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Dunn, G.P., Bruce, A.T., Ikeda, H., Old, L.J. & Schreiber, R.D. Nat. Immunol. 3, 991–998 (2002).

  2. 2

    Rideout, W.M. III, Eggan, K. & Jaenisch, R. Science 293, 1093–1098 (2001).

  3. 3

    van den Broek, M.F. et al. J. Exp. Med. 184, 1781–1790 (1996).

  4. 4

    Street, S.E., Cretney, E. & Smyth, M.J. Blood 97, 192–197 (2001).

  5. 5

    Cretney, E. et al. J. Immunol. 168, 1356–1361 (2002).

  6. 6

    Takeda, K. et al. J. Exp. Med. 195, 161–169 (2002).

  7. 7

    Shankaran, V. et al. Nature 410, 1107–1111 (2001).

  8. 8

    Enzler, T. et al. J. Exp. Med. 197, 1213–1219 (2003).

  9. 9

    Erdman, S. et al. Am. J. Pathol. 162, 691–702 (2003).

Download references

Acknowledgements

We thank E. Unanue (Washington University) M. Girardi (Yale University) and Schreiber lab members at Washington University, particularly G. Dunn, C. Koebel, H. Ikeda, B. Weaver, B. Judd and K. Sheehan for critical comments and suggestions.

Author information

Supplementary information

Supplementary Table 1

Supplementary Note 2

Rights and permissions

Reprints and Permissions

About this article

Further reading